109 related articles for article (PubMed ID: 21549100)
1. The ECS(SPSB) E3 ubiquitin ligase is the master regulator of the lifetime of inducible nitric-oxide synthase.
Matsumoto K; Nishiya T; Maekawa S; Horinouchi T; Ogasawara K; Uehara T; Miwa S
Biochem Biophys Res Commun; 2011 May; 409(1):46-51. PubMed ID: 21549100
[TBL] [Abstract][Full Text] [Related]
2. Regulation of inducible nitric-oxide synthase by the SPRY domain- and SOCS box-containing proteins.
Nishiya T; Matsumoto K; Maekawa S; Kajita E; Horinouchi T; Fujimuro M; Ogasawara K; Uehara T; Miwa S
J Biol Chem; 2011 Mar; 286(11):9009-19. PubMed ID: 21199876
[TBL] [Abstract][Full Text] [Related]
3. The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation.
Kuang Z; Lewis RS; Curtis JM; Zhan Y; Saunders BM; Babon JJ; Kolesnik TB; Low A; Masters SL; Willson TA; Kedzierski L; Yao S; Handman E; Norton RS; Nicholson SE
J Cell Biol; 2010 Jul; 190(1):129-41. PubMed ID: 20603330
[TBL] [Abstract][Full Text] [Related]
4. CHIP facilitates ubiquitination of inducible nitric oxide synthase and promotes its proteasomal degradation.
Chen L; Kong X; Fu J; Xu Y; Fang S; Hua P; Luo L; Yin Z
Cell Immunol; 2009; 258(1):38-43. PubMed ID: 19362296
[TBL] [Abstract][Full Text] [Related]
5. Hsp90 inhibition renders iNOS aggregation and the clearance of iNOS aggregates by proteasomes requires SPSB2.
Wang T; Luo S; Qin H; Xia Y
Free Radic Biol Med; 2018 Mar; 117():90-98. PubMed ID: 29367003
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the regulation of inducible nitric oxide synthase by the SPRY domain-containing SOCS box protein SPSB2, an E3 ubiquitin ligase.
Li K; You T; Zhao P; Luo Y; Zhang D; Wei H; Wang Y; Yang J; Guan X; Kuang Z
Nitric Oxide; 2021 Sep; 113-114():1-6. PubMed ID: 33862200
[TBL] [Abstract][Full Text] [Related]
7. The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins.
Bayle J; Lopez S; Iwaï K; Dubreuil P; De Sepulveda P
FEBS Lett; 2006 May; 580(11):2609-14. PubMed ID: 16643902
[TBL] [Abstract][Full Text] [Related]
8. TLR regulation of SPSB1 controls inducible nitric oxide synthase induction.
Lewis RS; Kolesnik TB; Kuang Z; D'Cruz AA; Blewitt ME; Masters SL; Low A; Willson T; Norton RS; Nicholson SE
J Immunol; 2011 Oct; 187(7):3798-805. PubMed ID: 21876038
[TBL] [Abstract][Full Text] [Related]
9. A critical role for CHIP in the aggresome pathway.
Sha Y; Pandit L; Zeng S; Eissa NT
Mol Cell Biol; 2009 Jan; 29(1):116-28. PubMed ID: 18955503
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Characterization of Cyclic Peptidomimetics of the Inducible Nitric Oxide Synthase Binding Epitope That Disrupt the Protein-Protein Interaction Involving SPRY Domain-Containing Suppressor of Cytokine Signaling Box Protein (SPSB) 2 and Inducible Nitric Oxide Synthase.
Harjani JR; Yap BK; Leung EW; Lucke A; Nicholson SE; Scanlon MJ; Chalmers DK; Thompson PE; Norton RS; Baell JB
J Med Chem; 2016 Jun; 59(12):5799-809. PubMed ID: 27214043
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitination of inducible nitric oxide synthase is required for its degradation.
Kolodziejski PJ; Musial A; Koo JS; Eissa NT
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12315-20. PubMed ID: 12221289
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitination of neuronal nitric-oxide synthase in the calmodulin-binding site triggers proteasomal degradation of the protein.
Clapp KM; Peng HM; Jenkins GJ; Ford MJ; Morishima Y; Lau M; Osawa Y
J Biol Chem; 2012 Dec; 287(51):42601-10. PubMed ID: 23109339
[TBL] [Abstract][Full Text] [Related]
13. Contribution of nitric oxide synthase isoforms to cholinergic vasodilation in murine retinal arterioles.
Gericke A; Goloborodko E; Sniatecki JJ; Steege A; Wojnowski L; Pfeiffer N
Exp Eye Res; 2013 Apr; 109():60-6. PubMed ID: 23434456
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the SPRY domain of human SPSB2 in the apo state.
Luo Y; Li K; Yang J; Zhang D; Zhou Y; Kuang Z
Acta Crystallogr F Struct Biol Commun; 2019 Jun; 75(Pt 6):412-418. PubMed ID: 31204687
[TBL] [Abstract][Full Text] [Related]
15. Arctigenin promotes degradation of inducible nitric oxide synthase through CHIP-associated proteasome pathway and suppresses its enzyme activity.
Yao X; Li G; Lü C; Xu H; Yin Z
Int Immunopharmacol; 2012 Oct; 14(2):138-44. PubMed ID: 22770942
[TBL] [Abstract][Full Text] [Related]
16. The SOCS box-adapting proteins for ubiquitination and proteasomal degradation.
Linossi EM; Nicholson SE
IUBMB Life; 2012 Apr; 64(4):316-23. PubMed ID: 22362562
[TBL] [Abstract][Full Text] [Related]
17. A Cyclic Peptide Inhibitor of the iNOS-SPSB Protein-Protein Interaction as a Potential Anti-Infective Agent.
Sadek MM; Barlow N; Leung EWW; Williams-Noonan BJ; Yap BK; Shariff FM; Caradoc-Davies TT; Nicholson SE; Chalmers DK; Thompson PE; Law RHP; Norton RS
ACS Chem Biol; 2018 Oct; 13(10):2930-2938. PubMed ID: 30226743
[TBL] [Abstract][Full Text] [Related]
18. iNOS-Derived Nitric Oxide Induces Integrin-Linked Kinase Endocytic Lysosome-Mediated Degradation in the Vascular Endothelium.
Reventun P; Alique M; Cuadrado I; Márquez S; Toro R; Zaragoza C; Saura M
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1272-1281. PubMed ID: 28546219
[TBL] [Abstract][Full Text] [Related]
19. E3 ubiquitin ligase CHIP interacts with C-type lectin-like receptor CLEC-2 and promotes its ubiquitin-proteasome degradation.
Shao M; Li L; Song S; Wu W; Peng P; Yang C; Zhang M; Duan F; Jia D; Zhang J; Wu H; Zhao R; Wang L; Ruan Y; Gu J
Cell Signal; 2016 Oct; 28(10):1530-6. PubMed ID: 27443248
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of the NOS2 interactome in human airway epithelial cells.
Foster MW; Thompson JW; Forrester MT; Sha Y; McMahon TJ; Bowles DE; Moseley MA; Marshall HE
Nitric Oxide; 2013 Nov; 34():37-46. PubMed ID: 23438482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
